What Is the Role of the Placebo Effect for Pain Relief in Neurorehabilitation? Clinical Implications From the Italian Consensus Conference on Pain in Neurorehabilitation

Gianluca Castelnuovo, Emanuele Maria Giusti, Gian Mauro Manzoni, Donatella Saviola, Samantha Gabrielli, Marco Lacerenza, Giada Pietrabissa, Roberto Cattivelli, Chiara Anna Maria Spatola, Alessandro Rossi, Giorgia Varallo, Margherita Novelli, Valentina Villa, Francesca Luzzati, Andrea Cottini, Carlo Lai, Eleonora Volpato, Cesare Cavalera, Francesco Pagnini, Valentina Tesio, Lorys Castelli, Mario Tavola, Riccardo Torta, Marco Arreghini, Loredana Zanini, Amelia Brunani, Ionathan Seitanidis, Giuseppe Ventura, Paolo Capodaglio, Guido Edoardo D'Aniello, Federica Scarpina, Andrea Brioschi, Matteo Bigoni, Lorenzo Priano, Alessandro Mauro, Giuseppe Riva, Daniele Di Lernia, Claudia Repetto, Camillo Regalia, Enrico Molinari, Paolo Notaro, Stefano Paolucci, Giorgio Sandrini, Susan Simpson, Brenda Kay Wiederhold, Santino Gaudio, Jeffrey B Jackson, Stefano Tamburin, Fabrizio Benedetti, Gianluca Castelnuovo, Emanuele Maria Giusti, Gian Mauro Manzoni, Donatella Saviola, Samantha Gabrielli, Marco Lacerenza, Giada Pietrabissa, Roberto Cattivelli, Chiara Anna Maria Spatola, Alessandro Rossi, Giorgia Varallo, Margherita Novelli, Valentina Villa, Francesca Luzzati, Andrea Cottini, Carlo Lai, Eleonora Volpato, Cesare Cavalera, Francesco Pagnini, Valentina Tesio, Lorys Castelli, Mario Tavola, Riccardo Torta, Marco Arreghini, Loredana Zanini, Amelia Brunani, Ionathan Seitanidis, Giuseppe Ventura, Paolo Capodaglio, Guido Edoardo D'Aniello, Federica Scarpina, Andrea Brioschi, Matteo Bigoni, Lorenzo Priano, Alessandro Mauro, Giuseppe Riva, Daniele Di Lernia, Claudia Repetto, Camillo Regalia, Enrico Molinari, Paolo Notaro, Stefano Paolucci, Giorgio Sandrini, Susan Simpson, Brenda Kay Wiederhold, Santino Gaudio, Jeffrey B Jackson, Stefano Tamburin, Fabrizio Benedetti

Abstract

Background: It is increasingly acknowledged that the outcomes of medical treatments are influenced by the context of the clinical encounter through the mechanisms of the placebo effect. The phenomenon of placebo analgesia might be exploited to maximize the efficacy of neurorehabilitation treatments. Since its intensity varies across neurological disorders, the Italian Consensus Conference on Pain in Neurorehabilitation (ICCP) summarized the studies on this field to provide guidance on its use.

Methods: A review of the existing reviews and meta-analyses was performed to assess the magnitude of the placebo effect in disorders that may undergo neurorehabilitation treatment. The search was performed on Pubmed using placebo, pain, and the names of neurological disorders as keywords. Methodological quality was assessed using a pre-existing checklist. Data about the magnitude of the placebo effect were extracted from the included reviews and were commented in a narrative form.

Results: 11 articles were included in this review. Placebo treatments showed weak effects in central neuropathic pain (pain reduction from 0.44 to 0.66 on a 0-10 scale) and moderate effects in postherpetic neuralgia (1.16), in diabetic peripheral neuropathy (1.45), and in pain associated to HIV (1.82). Moderate effects were also found on pain due to fibromyalgia and migraine; only weak short-term effects were found in complex regional pain syndrome. Confounding variables might have influenced these results.

Clinical implications: These estimates should be interpreted with caution, but underscore that the placebo effect can be exploited in neurorehabilitation programs. It is not necessary to conceal its use from the patient. Knowledge of placebo mechanisms can be used to shape the doctor-patient relationship, to reduce the use of analgesic drugs and to train the patient to become an active agent of the therapy.

Keywords: clinical psychology; consensus conference; health psychology; neurorehabilitation; pain; placebo; placebo effect.

Figures

Figure 1
Figure 1
Flowchart of the records search and selection.

References

    1. Benedetti F, Frisaldi E, Carlino E, Giudetti L, Pampallona A, Zibetti M, et al. Teaching neurons to respond to placebos. J Physiol (2016) 594:5647–60.10.1113/JP271322
    1. Dodd S, Dean OM, Vian J, Berk M. A review of the theoretical and biological understanding of the nocebo and placebo phenomena. Clin Ther (2017) 39:469–76.10.1016/j.clinthera.2017.01.010
    1. Benrud-Larson LM, Wegener ST. Chronic pain in neurorehabilitation populations: prevalence, severity and impact. NeuroRehabilitation (2000) 14:127–37.
    1. Magrinelli F, Zanette G, Tamburin S. Neuropathic pain: diagnosis and treatment. Pract Neurol (2013) 13:292–307.10.1136/practneurol-2013-000536
    1. Tamburin S, Paolucci S, Magrinelli F, Musicco M, Sandrini G. The Italian Consensus Conference on Pain in Neurorehabilitation: rationale and methodology. J Pain Res (2016) 9:311–8.10.2147/JPR.S84646
    1. Klinger R, Flor H. Clinical and ethical implications of placebo effects: enhancing patients’ benefits from pain treatment. Handb Exp Pharmacol (2014) 225:217–35.10.1007/978-3-662-44519-8_13
    1. Miller FG, Kaptchuk TJ. The power of context: reconceptualizing the placebo effect. J R Soc Med (2008) 101:222–5.10.1258/jrsm.2008.070466
    1. Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol (2008) 59:565–90.10.1146/annurev.psych.59.113006.095941
    1. Crane GS. Harnessing the placebo effect: a new model for mind-body healing mechanisms. Int J Trans Stud (2016) 35:39–51.10.24972/ijts.2016.35.1.39
    1. Benedetti F. Placebo and the new physiology of the doctor-patient relationship. Physiol Rev (2013) 93:1207–46.10.1152/physrev.00043.2012
    1. Benedetti F. Placebo-induced improvements: how therapeutic rituals affect the patient’s brain. J Acupunct Meridian Stud (2012) 5:97–103.10.1016/j.jams.2012.03.001
    1. Colagiuri B, Schenk LA, Kessler MD, Dorsey SG, Colloca L. The placebo effect: from concepts to genes. Neuroscience (2015) 307:171–90.10.1016/j.neuroscience.2015.08.017
    1. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet (1978) 2:654–7.10.1016/S0140-6736(78)92762-9
    1. Benedetti F, Amanzio M, Casadio C, Oliaro A, Maggi G. Blockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide. Pain (1997) 71:135–40.10.1016/S0304-3959(97)03346-0
    1. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci (1999) 19:484–94.10.1523/JNEUROSCI.19-01-00484.1999
    1. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK. Individual differences in reward responding explain placebo-induced expectations and effects. Neuron (2007) 55:325–36.10.1016/j.neuron.2007.06.028
    1. Scott DJ, Stohler CS, Egnatuk CM, Wang H, Koeppe RA, Zubieta JK. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry (2008) 65:220–31.10.1001/archgenpsychiatry.2007.34
    1. Eippert F, Bingel U, Schoell ED, Yacubian J, Klinger R, Lorenz J, et al. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron (2009) 63:533–43.10.1016/j.neuron.2009.07.014
    1. Zubieta J-K, Stohler CS. Neurobiological mechanisms of placebo responses. Ann N Y Acad Sci (2009) 1156:198–210.10.1111/j.1749-6632.2009.04424.x
    1. Benedetti F, Amanzio M, Rosato R, Blanchard C. Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors. Nat Med (2011) 17:1228–30.10.1038/nm.2435
    1. Carlino E, Piedimonte A, Benedetti F. Nature of the placebo and nocebo effect in relation to functional neurologic disorders. Handb Clin Neurol (2017) 139:597–606.10.1016/B978-0-12-801772-2.00048-5
    1. Wang RS, Hall KT, Giulianini F, Passow D, Kaptchuk TJ, Loscalzo J. Network analysis of the genomic basis of the placebo effect. JCI Insight (2017) 2:93911.10.1172/jci.insight.93911
    1. Hall KT, Loscalzo J, Kaptchuk T. Pharmacogenomics and the placebo response. ACS Chem Neurosci (2018) 9(4):633–5.10.1021/acschemneuro.8b00078
    1. Wager TD, Atlas LY, Leotti LA, Rilling JK. Predicting individual differences in placebo analgesia: contributions of brain activity during anticipation and pain experience. J Neurosci (2011) 31:439–52.10.1523/JNEUROSCI.3420-10.2011
    1. Geers AL, Helfer SG, Kosbab K, Weiland PE, Landry SJ. Reconsidering the role of personality in placebo effects: dispositional optimism, situational expectations, and the placebo response. J Psychosom Res (2005) 58:121–7.10.1016/j.jpsychores.2004.08.011
    1. Morton DL, Watson A, El-Deredy W, Jones AK. Reproducibility of placebo analgesia: effect of dispositional optimism. Pain (2009) 146:194–8.10.1016/j.pain.2009.07.026
    1. Geers AL, Wellman JA, Fowler SL, Helfer SG, France CR. Dispositional optimism predicts placebo analgesia. J Pain (2010) 11:1165–71.10.1016/j.jpain.2010.02.014
    1. Pecina M, Azhar H, Love TM, Lu T, Fredrickson BL, Stohler CS, et al. Personality trait predictors of placebo analgesia and neurobiological correlates. Neuropsychopharmacology (2013) 38:639–46.10.1038/npp.2012.227
    1. Darragh M, Booth RJ, Consedine NS. Who responds to placebos? Considering the “placebo personality” via a transactional model. Psychol Health Med (2015) 20:287–95.10.1080/13548506.2014.936885
    1. De Pascalis V, Chiaradia C, Carotenuto E. The contribution of suggestibility and expectation to placebo analgesia phenomenon in an experimental setting. Pain (2002) 96:393–402.10.1016/S0304-3959(01)00485-7
    1. Raz A. Genetics and neuroimaging of attention and hypnotizability may elucidate placebo. Int J Clin Exp Hypn (2008) 56:99–116.10.1080/00207140701506482
    1. Van Der Meulen M, Kamping S, Anton F. The role of cognitive reappraisal in placebo analgesia: an fMRI study. Soc Cogn Affect Neurosci (2017) 12(7):1128–37.10.1093/scan/nsx033
    1. Watkinson A, Chapman SC, Horne R. Beliefs about pharmaceutical medicines and natural remedies explain individual variation in placebo analgesia. J Pain (2017) 18(8):908–22.10.1016/j.jpain.2017.02.435
    1. Colloca L, Benedetti F. How prior experience shapes placebo analgesia. Pain (2006) 124:126–33.10.1016/j.pain.2006.04.005
    1. Schweinhardt P, Seminowicz DA, Jaeger E, Duncan GH, Bushnell MC. The anatomy of the mesolimbic reward system: a link between personality and the placebo analgesic response. J Neurosci (2009) 29:4882–7.10.1523/JNEUROSCI.5634-08.2009
    1. Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc (2015) 13:132–40.10.1097/XEB.0000000000000055
    1. Mbizvo GK, Nolan SJ, Nurmikko TJ, Goebel A. Placebo responses in long-standing complex regional pain syndrome: a systematic review and meta-analysis. J Pain (2015) 16:99–115.10.1016/j.jpain.2014.11.008
    1. Hauser W, Sarzi-Puttini P, Tolle TR, Wolfe F. Placebo and nocebo responses in randomised controlled trials of drugs applying for approval for fibromyalgia syndrome treatment: systematic review and meta-analysis. Clin Exp Rheumatol (2012) 30:78–87.
    1. Loder E, Goldstein R, Biondi D. Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls. Cephalalgia (2005) 25:124–31.10.1111/j.1468-2982.2004.00817.x
    1. Macedo A, Banos JE, Farre M. Placebo response in the prophylaxis of migraine: a meta-analysis. Eur J Pain (2008) 12:68–75.10.1016/j.ejpain.2007.03.002
    1. Meissner K, Fassler M, Rucker G, Kleijnen J, Hrobjartsson A, Schneider A, et al. Differential effectiveness of placebo treatments: a systematic review of migraine prophylaxis. JAMA Intern Med (2013) 173:1941–51.10.1001/jamainternmed.2013.10391
    1. Cragg JJ, Warner FM, Finnerup NB, Jensen MP, Mercier C, Richards JS, et al. Meta-analysis of placebo responses in central neuropathic pain: impact of subject, study, and pain characteristics. Pain (2016) 157:530–40.10.1097/j.pain.0000000000000431
    1. Arakawa A, Kaneko M, Narukawa M. An investigation of factors contributing to higher levels of placebo response in clinical trials in neuropathic pain: a systematic review and meta-analysis. Clin Drug Investig (2015) 35:67–81.10.1007/s40261-014-0259-1
    1. Cepeda MS, Berlin JA, Gao CY, Wiegand F, Wada DR. Placebo response changes depending on the neuropathic pain syndrome: results of a systematic review and meta-analysis. Pain Med (2012) 13:575–95.10.1111/j.1526-4637.2012.01340.x
    1. Quessy SN, Rowbotham MC. Placebo response in neuropathic pain trials. Pain (2008) 138:479–83.10.1016/j.pain.2008.06.024
    1. Tuttle AH, Tohyama S, Ramsay T, Kimmelman J, Schweinhardt P, Bennett GJ, et al. Increasing placebo responses over time in U.S. clinical trials of neuropathic pain. Pain (2015) 156:2616–26.10.1097/j.pain.0000000000000333
    1. Madsen MV, Gotzsche PC, Hrobjartsson A. Acupuncture treatment for pain: systematic review of randomised clinical trials with acupuncture, placebo acupuncture, and no acupuncture groups. BMJ (2009) 338:a3115.10.1136/bmj.a3115
    1. Naleschinski D, Baron R. Complex regional pain syndrome type I: neuropathic or not? Curr Pain Headache Rep (2010) 14:196–202.10.1007/s11916-010-0115-9
    1. Amanzio M, Corazzini LL, Vase L, Benedetti F. A systematic review of adverse events in placebo groups of anti-migraine clinical trials. Pain (2009) 146:261–9.10.1016/j.pain.2009.07.010
    1. Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis (2008) 67:1716–23.10.1136/ard.2008.092015
    1. Bannuru RR, Mcalindon TE, Sullivan MC, Wong JB, Kent DM, Schmid CH. Effectiveness and implications of alternative placebo treatments: a systematic review and network meta-analysis of osteoarthritis trials. Ann Intern Med (2015) 163:365–72.10.7326/M15-0623
    1. Kuten-Shorrer M, Kelley JM, Sonis ST, Treister NS. Placebo effect in burning mouth syndrome: a systematic review. Oral Dis (2014) 20:e1–6.10.1111/odi.12192
    1. Capurso G, Cocomello L, Benedetto U, Camma C, Delle Fave G. Meta-analysis: the placebo rate of abdominal pain remission in clinical trials of chronic pancreatitis. Pancreas (2012) 41:1125–31.10.1097/MPA.0b013e318249ce93
    1. Hrobjartsson A, Gotzsche PC. Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. J Intern Med (2004) 256:91–100.10.1111/j.1365-2796.2004.01355.x
    1. Wager TD, Fields HL. Placebo analgesia. 6th ed In: Mcmahon SB, Koltzenburg M, Tracey I, Turk D, editors. Wall and Melzack’s Textbook of Pain. Philadelhia, PA: Elsevier Saunders; (2013). p. 362–73.
    1. Vase L, Skyt I, Hall KT. Placebo, nocebo, and neuropathic pain. Pain (2016) 157(Suppl 1):S98–105.10.1097/j.pain.0000000000000445
    1. Vase L, Petersen GL, Riley JL, III, Price DD. Factors contributing to large analgesic effects in placebo mechanism studies conducted between 2002 and 2007. Pain (2009) 145:36–44.10.1016/j.pain.2009.04.008
    1. Bartolo M, Chio A, Ferrari S, Tassorelli C, Tamburin S, Avenali M, et al. Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation. Eur J Phys Rehabil Med (2016) 52:841–54.
    1. Castelnuovo G, Giusti EM, Manzoni GM, Saviola D, Gatti A, Gabrielli S, et al. Psychological considerations in the assessment and treatment of pain in neurorehabilitation and psychological factors predictive of therapeutic response: evidence and recommendations from the Italian consensus conference on pain in neurorehabilitation. Front Psychol (2016) 7:468.10.3389/fpsyg.2016.00468
    1. Castelnuovo G, Giusti EM, Manzoni GM, Saviola D, Gatti A, Gabrielli S, et al. Psychological treatments and psychotherapies in the neurorehabilitation of pain: evidences and recommendations from the Italian consensus conference on pain in neurorehabilitation. Front Psychol (2016) 7:115.10.3389/fpsyg.2016.00115
    1. Ferraro F, Jacopetti M, Spallone V, Padua L, Traballesi M, Brunelli S, et al. Diagnosis and treatment of pain in plexopathy, radiculopathy, peripheral neuropathy and phantom limb pain. Evidence and recommendations from the Italian Consensus Conference on Pain on Neurorehabilitation. Eur J Phys Rehabil Med (2016) 52:855–66.
    1. Paolucci S, Martinuzzi A, Scivoletto G, Smania N, Solaro C, Aprile I, et al. Assessing and treating pain associated with stroke, multiple sclerosis, cerebral palsy, spinal cord injury and spasticity. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation. Eur J Phys Rehabil Med (2016) 52:827–40.
    1. Picelli A, Buzzi MG, Cisari C, Gandolfi M, Porru D, Bonadiman S, et al. Headache, low back pain, other nociceptive and mixed pain conditions in neurorehabilitation. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation. Eur J Phys Rehabil Med (2016) 52:867–80.
    1. Tamburin S, Lacerenza MR, Castelnuovo G, Agostini M, Paolucci S, Bartolo M, et al. Pharmacological and non-pharmacological strategies in the integrated treatment of pain in neurorehabilitation. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation. Eur J Phys Rehabil Med (2016) 52:741–52.
    1. Kaptchuk TJ, Friedlander E, Kelley JM, Sanchez MN, Kokkotou E, Singer JP, et al. Placebos without deception: a randomized controlled trial in irritable bowel syndrome. PLoS One (2010) 5:e15591.10.1371/journal.pone.0015591
    1. Kam-Hansen S, Jakubowski M, Kelley JM, Kirsch I, Hoaglin DC, Kaptchuk TJ, et al. Altered placebo and drug labeling changes the outcome of episodic migraine attacks. Sci Transl Med (2014) 6:218ra215.10.1126/scitranslmed.3006175
    1. Carvalho C, Caetano JM, Cunha L, Rebouta P, Kaptchuk TJ, Kirsch I. Open-label placebo treatment in chronic low back pain: a randomized controlled trial. Pain (2016) 157:2766–72.10.1097/j.pain.0000000000000700
    1. Charlesworth JEG, Petkovic G, Kelley JM, Hunter M, Onakpoya I, Roberts N, et al. Effects of placebos without deception compared with no treatment: a systematic review and meta-analysis. J Evid Based Med (2017) 10:97–107.10.1111/jebm.12251
    1. Locher C, Frey Nascimento A, Kirsch I, Kossowsky J, Meyer A, Gaab J. Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia. Pain (2017) 158(12):2320–8.10.1097/j.pain.0000000000001012
    1. Mundt JM, Roditi D, Robinson ME. A comparison of deceptive and non-deceptive placebo analgesia: efficacy and ethical consequences. Ann Behav Med (2017) 51:307–15.10.1007/s12160-016-9854-0
    1. Martin AL, Katz J. Inclusion of authorized deception in the informed consent process does not affect the magnitude of the placebo effect for experimentally induced pain. Pain (2010) 149:208–15.10.1016/j.pain.2009.12.004
    1. Brody H. The lie that heals: the ethics of giving placebos. Ann Intern Med (1982) 97:112–8.10.7326/0003-4819-97-1-112
    1. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Placebo effects: biological, clinical and ethical advances. Lancet (2010) 375:686–95.10.1016/S0140-6736(09)61706-2
    1. Enck P, Bingel U, Schedlowski M, Rief W. The placebo response in medicine: minimize, maximize or personalize? Nat Rev Drug Discov (2013) 12:191–204.10.1038/nrd3923
    1. Klinger R, Colloca L, Bingel U, Flor H. Placebo analgesia: clinical applications. Pain (2014) 155:1055–8.10.1016/j.pain.2013.12.007
    1. Bystad M, Bystad C, Wynn R. How can placebo effects best be applied in clinical practice? A narrative review. Psychol Res Behav Manage (2015) 8:41–5.10.2147/PRBM.S75670
    1. Doering BK, Rief W. Utilizing placebo mechanisms for dose reduction in pharmacotherapy. Trends Pharmacol Sci (2012) 33:165–72.10.1016/j.tips.2011.12.001
    1. Barrett B, Muller D, Rakel D, Rabago D, Marchand L, Scheder JC. Placebo, meaning, and health. Perspect Biol Med (2006) 49:178–98.10.1353/pbm.2006.0019

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj